Interscalene Versus Combined Infraclavicular-suprascapular Nerve Blocks

Postoperative Pain Clinical Trial

Official title:

The Analgesic Efficacy and Hemi-diaphragmatic Paralysis Assessment of Combined Infraclavicular-suprascapular Nerve Blocks Versus Standard Interscalene Brachial Plexus Block for Arthroscopic Rotator Cuff Repair

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03628950
• Other study ID #: D165
• Status: Completed
• Phase: N/A
• Start date: September 1, 2018
• Est. completion date: September 30, 2020

Study information

• Verified date: March 2022
• Source: Fayoum University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this trial is to compare the analgesic efficiency and hemi-diaphragmatic paralysis of the standard ultrasound-guided interscalene (ISB) brachial plexus block with the combined use of costoclavicular approach of infraclavicular brachial plexus block and suprascapular nerve block (ICB-SSB) for patients undergoing arthroscopic rotator cuff repair.

Authors hypothesize that the combined use of ICB-SSB could lead to equivalent postoperative analgesic effect to the standard ISB with less hemi-diaphragmatic paralysis.

Description:

The interscalene block main hindrance is the high risk of ipsilateral phrenic nerve block with sequential hemi-diaphragmatic paralysis.The combined use of conventional paracoracoid infraclavicular block (ICB) and suprascapular block (SSB) was not equivalent to the standard ISB regarding the analgesic efficacy , but has no hemi-diaphragmatic affection for patients undergone shoulder arthroscopic procedures.ICB can be achieved by another approach (costoclavicular) which blocks the brachial plexus at the mid infraclavicular fossa The patients scheduled for an elective arthroscopic rotator cuff repair will be randomly allocated by a computer-gener¬ated table into one of two study groups. The randomization sequence will be concealed in opaque sealed envelopes. The envelopes will be opened by the study investigators just after recruitments and admission to the operation room. Only assessors and data collectors will be blinded to the groups allocations.

Preoperative preparation:

Preoperative investigations will be done according to the local protocol designed to evaluate the patients. It includes complete blood count, blood sugar level, serum urea and creatinine, liver function tests, coagulation profile and electrocardiogram (ECG).

Intraoperative Management of Patients:

After arrival to the induction room, a 20G intravenous catheter will be placed in the upper limb opposite to the surgical site, and intravenous premedication (midazolam 2 mg and fentanyl 50 µg) will be administered to all patients. Supplemental oxygen (nasal cannulae at 2 Lmin-1), standard ASA monitoring (5-lead ECG, noninvasive blood pressure (NIBP), and pulse oximetry) will be applied throughout the procedure. All blocks will be performed under real-time ultrasound guidance (Philips clear vue350, Philips healthcare, Andover MA01810, USA).

The patients in both groups will initially receive superficial cervical plexus block. The block will be performed in supine position with the patients' head turned to the other side. Once the skin is appropriately cleaned and prepared with anti-septic, the high frequency linear array transducer (8-15 megahertz) will be placed over the lateral side of the neck at the midpoint of the posterior border of the sternocleidomastoid muscle(SCM). The transducer is positioned such that the tapering end (posterior border on the ultrasound image) of the SCM is in the center of the screen. The block needle (22-gauge, 50 mm, Stimuplex D®; B Braun, Germany) is then introduced from the posterior aspect through the skin and platysma and 10 ml of local anesthetic(LA) deposited just behind this landmark. Afterthat the patients will receive either ISB or ICB-SSB.

Following completion of the assessments of sensorimotor blocks at 30 min (see below), induction of general anesthesia will be achieved by intravenous propofol 1.5-2 mgkg-1, fentanyl 1 ugkg-1, and atracurium 0.5 mgkg-1. General anesthesia will be maintained by isoflurane 1.5 volume % in 2 lmin-1 oxygen-air mixture 50:50 and atracurium 0.1 mgkg-1 every 30 minutes. All subjects will be placed in the beach chair position slowly, and the surgical procedures will be completed by the same surgical team.

Intraoperatively, if the patient's heart rate or blood pressure exceeded 20% of the preoperative value, a 50-µg bolus dose of fentanyl will be administered. Deliberate hypotension technique will be used to keep systolic blood pressure at 90-100 mmHg range, mean blood pressure at 65-75 mmHg range, and heart rate at 60-70 bpm range by nitroglycerine intravenous infusion at a rate of 1-2 µgkg-1min-1. If excessive unwanted hypotension (systolic blood pressure less than 90 mmHg or mean blood pressure less than 65 mmHg) will be noted, 200 ml ringer acetate fluid bolus will be administered to regain the blood pressure to the desired range with reducing the infusion rate of nitroglycerine or stop it temporarily. Otherwise, 5 mg ephedrine increments will be used to secure save blood pressure readings range. Bradycardia (HR less than 50 bpm) will be corrected by atropine sulphate administration at a dose of 30 µg increments.

Assessment of Sensory and Motor Blockade:

• The extent of motor and sensory blockade will be evaluated by an anesthesiologist who will not be involved in the brachial plexus block 30 min after local anesthetics administration. Using an alcohol swab, the sensory blockade will be tested on the skin overlying the clavicle (supraclavicular nerves) and the lateral surface of the deltoid (axillary nerve). Each territory will be graded according to a three-point scale using a cold test: 0 = no block; 1 = analgesia (patient can feel touch, not cold); 2 = anesthesia (patient cannot feel touch).

• Motor function will be tested using shoulder abduction (axillary and suprascapular nerves) and external shoulder rotation (suprascapular nerve) according a three-point scale: 0 = no block; 1 = paresis; 2 = paralysis. blocks will be considered complete if, at 30 min, a global composite score six points (out of a maximum of eight points) will be achieved,5 incidence of complete block 30 minutes after injection will be recoded.

Assessment of hemi-diaphragmatic paralysis (HDP) using Ultrasound:

Ultrasound evaluation of the hemi-diaphragm will be assessed by a blinded trained radiologist. A low-frequency (2 to 5 MHz) curvilinear array transducer will be placed in the coronal plane at the midaxillary line to obtain an intercostal view. At the level of ribs eight to nine on the left and seven to eight on the right, the spleen or liver are centered with the rib shadows on either side. On deep inspiration, caudal descent of the liver or spleen precedes descent of the bright pleural line. The transducer will then be moved in both caudal and cephalad directions to visualize the end-inspiratory and end-expiratory levels of the pleural line, respectively, which will be then marked on the patient's skin. This process will be repeated before, after the chosen regional anesthetic technique and after recovery from general anesthesia in post-anesthetic care unit (PACU) with the patient in the same position. Minimal change signifies no block, but a reduction in this distance represents phrenic nerve block.

Postoperative Evaluation:

After completion of the surgical procedure, the patients extubated after fulfilment of the extubation criteria and then will be transferred to PACU for 2 h assessment. At PACU all patients will receive ketoprofen 100 mg and acetaminophen 1 gram by intravenous infusion over 30 min. Postoperative pain will be rated on a numerical scale ranging (NRS) from 0 (no pain) to 10 (worst imaginable pain) at 1-hr at PACU then at 4, 8, 12, and 24 hours postoperatively. The patients discharged to ward after fulfilment of discharge criteria and modified Aldrete score ≥9. ketoprofen 100 mg/12 h and acetaminophen 1 gram/8 h by intravenous infusion over 30 min will be continued for 48 h as parts of the postoperative pain control policy of the institution. Assessment of postoperative analgesia duration by recording the time of first request of analgesia. The duration of anesthesia time (defined as the time between the end of the local anesthetic injection for brachial plexus block and the postoperative administration of analgesic agents) will be recorded. Patients with NRS>5 will receive morphine sulphate IV at a bolus dose of 2-5 mg increments with maximum dose of 20 mg at 4 hours or 40 mg at 24 hours. Cumulative and interval amount of morphine consumption in 24 h will be recorded.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 66
• Est. completion date: September 30, 2020
• Est. primary completion date: August 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• American Society association (ASA) physical status I to III patients who will be scheduled for an elective arthroscopic rotator cuff repair.

Exclusion Criteria

• Patient refusal

• preexisting (obstructive or restrictive) pulmonary disease or low baseline oxygen saturation

• contraindication to regional anesthesia (coagulopathy, allergy to local anesthetic, sever thrombocytopenia, pre-existing neuropathy in operative limb, infection at puncture site).

• sepsis

• hepatic or renal dysfunction.

• Advanced cardiovascular diseases

• chronic pain condition requiring the intake of opioids at home.

• prior surgery in the neck or infraclavicular/suprascapular fossa.

Related Conditions & MeSH terms

• Pain, Postoperative
• Postoperative Pain

Intervention

Procedure:
• ICSSB group
At supine position with abducted limb, the probe of ultrasound will be translocated in costoclavicular space; the subclavian artery will be identified. The three cords of the brachial plexus will be visualized lateral to the artery. By using an in-plane technique and a cephalad-to-caudate direction, the block needle will be advanced until its tip will be in the middle of three cords and 10 mL of 0.25 % bupivacaine Hydrochloride will be injected. Then at lateral decubitus position, by using in-plane technique the probe will be translocated in suprascapular fossa, lateral-to-medial direction, the block needle will be advanced until its tip in the floor of the suprascapular fossa ventral to the fascia of the supraspinatus muscle and 10 mL of 0.25 % bupivacaine Hydrochloride will be injected .
• ISB group
The probe of ultrasound will be applied in lateral side of the neck at the level of the cricoid cartilage to obtain a view of the three hypoechoic structures which represent the roots of the brachial plexus. Using an in-plane technique and a lateral to-medial direction, the block needle will be advanced until its tip will be positioned under the prevertebral fascia between the two most superficial hypoechoic structures and 10 mL of 0.25 % bupivacaine Hydrochloride will be injected at level of C5-6 and another 10 ml of 0.25 % bupivacaine Hydrochloride will be injected at level of C7-8.

Locations

Country	Name	City	State
Egypt	Fayoum University hospital	Madinat al Fayyum	Faiyum Governorate

Sponsors (1)

Lead Sponsor	Collaborator
Fayoum University Hospital

Country where clinical trial is conducted

Egypt, 

References & Publications (5)

Aliste J, Bravo D, Finlayson RJ, Tran DQ. A randomized comparison between interscalene and combined infraclavicular-suprascapular blocks for arthroscopic shoulder surgery. Can J Anaesth. 2018 Mar;65(3):280-287. doi: 10.1007/s12630-017-1048-0. Epub 2017 Dec 19. — View Citation

Karmakar MK, Sala-Blanch X, Songthamwat B, Tsui BC. Benefits of the costoclavicular space for ultrasound-guided infraclavicular brachial plexus block: description of a costoclavicular approach. Reg Anesth Pain Med. 2015 May-Jun;40(3):287-8. doi: 10.1097/AAP.0000000000000232. — View Citation

Tran DQ, Elgueta MF, Aliste J, Finlayson RJ. Diaphragm-Sparing Nerve Blocks for Shoulder Surgery. Reg Anesth Pain Med. 2017 Jan/Feb;42(1):32-38. doi: 10.1097/AAP.0000000000000529. Review. — View Citation

Ullah H, Samad K, Khan FA. Continuous interscalene brachial plexus block versus parenteral analgesia for postoperative pain relief after major shoulder surgery. Cochrane Database Syst Rev. 2014 Feb 4;(2):CD007080. doi: 10.1002/14651858.CD007080.pub2. Review. — View Citation

Urmey WF, Talts KH, Sharrock NE. One hundred percent incidence of hemidiaphragmatic paresis associated with interscalene brachial plexus anesthesia as diagnosed by ultrasonography. Anesth Analg. 1991 Apr;72(4):498-503. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The cumulative morphine consumption at first 24 hours postoperatively.	in milligram	24 hours after recovery from general anesthesia
Secondary	Assessment of hemidiaphragmatic paralysis	By using abdominal ultrasonography examination	5 minutes before intervention
Secondary	Assessment of hemidiaphragmatic paralysis	By using abdominal ultrasonography examination	5 minutes after intervention
Secondary	Assessment of hemidiaphragmatic paralysis by abdominal ultrasound examination	By using abdominal ultrasonography examination	10 minutes after recovery from general anesthesia
Secondary	Assessment of postoperative pain	using numerical rate scale (NRS)(where 0=no headache and 10 = worst imaginable headache )	1 hour after recovery from general anesthesia
Secondary	Assessment of postoperative pain	using numerical rate scale (NRS)(where 0=no headache and 10 = worst imaginable headache )	4 hours after recovery from general anesthesia
Secondary	Assessment of postoperative pain	using numerical rate scale (NRS)(where 0=no headache and 10 = worst imaginable headache )	8 hours after recovery from general anesthesia
Secondary	Assessment of postoperative pain	using numerical rate scale (NRS)(where 0=no headache and 10 = worst imaginable headache )	12 hours after recovery from general anesthesia
Secondary	Assessment of postoperative pain	using numerical rate scale (NRS)(where 0=no headache and 10 = worst imaginable headache )	24 hours after recovery from general anesthesia
Secondary	Assessment of postoperative pain	using numerical rate scale (NRS)(where 0=no headache and 10 = worst imaginable headache )	48 hours after recovery from general anesthesia
Secondary	Interval morphine consumption dose	in milligram	at 2 hours after recovery from general anesthesia
Secondary	Interval morphine consumption dose	in milligram	at 4 hours after recovery from general anesthesia
Secondary	Interval morphine consumption dose	in milligram	at 8 hours after recovery from general anesthesia
Secondary	Interval morphine consumption dose	in milligram	at 12 hours after recovery from general anesthesia
Secondary	Interval morphine consumption dose	in milligram	at 24 hours after recovery from general anesthesia
Secondary	Interval morphine consumption dose	in milligram	at 48 hours after recovery from general anesthesia
Secondary	Incidence of complete sensory block	using alcohol swab according to three point scale where 0= no block 1=analgesia (patient can feel touch not cold) 2=anesthesia (patient cannot feel touch)	30 minutes after end of local anesthetic injection
Secondary	Incidence of complete motor block	using shoulder abduction and external rotation according to three point scale where 0= no block 1=paresis 2=paralysis	30 minutes after end of local anesthetic injection
Secondary	Intraoperative fentanyl dose consumption	In microgram	At the end of surgical procedure
Secondary	Incidence of nausea	Opioid-related side effect	24 hours postoperative
Secondary	Incidence of vomiting	Opioid-related side effect	24 hours postoperative
Secondary	Incidence of pruritus	Opioid-related side effect	24 hours postoperative
Secondary	Incidence of excessive sedation	Opioid-related side effect	24 hours postoperative
Secondary	Incidence of respiratory depression	Opioid-related side effect	24 hours postoperative
Secondary	Incidence of urine retention	Opioid-related side effect	24 hours postoperative
Secondary	time to first rescue analgesia	in minutes	from recovery of general anesthesia up to 24 hours postoperativly
Secondary	duration of the surgical procedure	in minutes	At the end of surgical procedure
Secondary	performance time of the intervention	time from skin disinfection until the end of local anesthetic injection	1 minute immediately after end of local anesthetic injection
Secondary	Incidence of vascular puncture	potential adverse events from intervention	within 3 seconds during performance of the blocks
Secondary	Incidence of local anesthetic toxicity	potential adverse events from intervention	30 minutes after performance of the blocks.
Secondary	Incidence of paresthesia	potential adverse events from intervention	within 1 second during performance of the blocks
Secondary	Incidence of Horner syndrome	potential adverse events from intervention	30 minutes after performance of the blocks.
Secondary	Incidence of hoarseness of voice	potential adverse events from intervention	30 minutes after performance of the blocks.
Secondary	Age	in years	6 hours before intervention
Secondary	weight	in kilogram(kg)	6 hours before intervention
Secondary	height	in meters(m)	6 hours before intervention
Secondary	body mass index	in kg/m square	6 hours before intervention
Secondary	Assessment of patients' satisfaction score for postoperative analgesia	poor=0; fair=1; good=2; excellent=3	after 72 hours postoperative
Secondary	Assessment of surgeon's' satisfaction score	poor=0; fair=1; good=2; excellent=3	At the end of surgical procedure